Treatment for recurrent epithelial ovarian cancer

Treatment for recurrent epithelial ovarian cancer

Bibliographic Details
Main Authors:	Yiu-Tai Li, Chia-Hao Liu, Peng-Hui Wang
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	Taiwanese Journal of Obstetrics & Gynecology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1028455921001753

Similar Items

Treatment of recurrent epithelial ovarian cancer
by: Carmela Pisano, et al.
Published: (2009-06-01)

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
by: Karina Dahl Steffensen, et al.
Published: (2011-01-01)

Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer
by: Qinghong Hu, et al.
Published: (2020-07-01)

Treatment of liver metastases in patients with epithelial ovarian cancer
by: Hao Deng, et al.
Published: (2021-05-01)

Dietary and lifestyle modifications in the prevention of epithelial ovarian cancer recurrence
by: Torres, Alexandra
Published: (2018)

The role of pemetrexed in recurrent epithelial ovarian cancer: a scoping review
by: Michael Roche, et al.
Published: (2018-03-01)

Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment
by: Efnan Algin, et al.
Published: (2016-08-01)

Advances in treatment of epithelial ovarian cancer
by: Kikkawa, Fumitaka, et al.
Published: (2006)

Palbociclib in the treatment of recurrent ovarian cancer
by: Dai Wee Lee, et al.
Published: (2020-11-01)

Efficacy And Safety Of Apatinib Treatment In Platinum-Resistant Recurrent Epithelial Ovarian Cancer: A Real World Study
by: Zhang J, et al.
Published: (2019-11-01)

Prognostic Factors for Different Treatment Regimens in Advanced Epithelial Ovarian Cancer
by: LIU Chuanzhong, et al.
Published: (2018-10-01)

The detection, treatment, and biology of epithelial ovarian cancer
by: Gubbels Jennifer AA, et al.
Published: (2010-03-01)

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses
by: Zhengmao Zhang, et al.
Published: (2019-03-01)

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
by: Elit L, et al.
Published: (2013-02-01)

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins
by: Gui T, et al.
Published: (2014-09-01)

Treatment for Recurrent Ovarian Cancer—At First Relapse
by: Kimio Ushijima
Published: (2010-01-01)

Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition
by: Jiani Yang, et al.
Published: (2021-03-01)

The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: The Kaohsiung Chang Gung experience
by: Ching-Fen Hu, et al.
Published: (2015-02-01)

Combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as a treatment for recurrent epithelial ovarian cancer-National Cancer Institute experience
by: Mohamed Ibrahim Fahim, et al.
Published: (2018-12-01)

Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.
by: Yong-Man Kim, et al.
Published: (2014-01-01)

Treatment of an Advanced Ovarian Cancer Patient Receiving Hemodialysis
by: Tai-Jong Chao, et al.
Published: (2007-12-01)

Endometriosis and the subsequent risk of epithelial ovarian cancer
by: Wen-Hsun Chang, et al.
Published: (2014-12-01)

Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer
by: Yang C, et al.
Published: (2020-02-01)

An analysis of biomarkers for epithelial ovarian cancer
by: Wang, Yuepeng
Published: (2012)

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
by: Sudeep Gupta, et al.
Published: (2019-11-01)

The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
by: Cai M. Roberts, et al.
Published: (2019-07-01)

Ludartin treatment exhibits promising inhibitory effect on the epithelial ovarian cancer growth and metastasis
by: Lin Bai, et al.
Published: (2016-06-01)

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
by: Veronica Rojas, et al.
Published: (2016-12-01)

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
by: Lilian T. Gien, et al.
Published: (2010-01-01)

Clinical utility of targeted treatments in the management of epithelial ovarian cancer
by: Twu C, et al.
Published: (2012-07-01)

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer
by: Davidson BA, et al.
Published: (2014-03-01)

The discovery and evaluation of treatment stratification biomarkers in epithelial ovarian cancer
by: Borley, Jane Victoria
Published: (2013)

Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
by: Eva María Guerra Alía, et al.
Published: (2019-06-01)

The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
by: K. E. Borisov
Published: (2014-07-01)

Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
by: Zhongyu Wang, et al.
Published: (2021-07-01)

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
by: Gallagher William M, et al.
Published: (2010-04-01)

Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series
by: Koji Matsuo, et al.
Published: (2018-08-01)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
by: Sandeep Kumar Parvathareddy, et al.
Published: (2021-05-01)

Ruptured ovarian endometriotic cysts
by: Yiu-Tai Li
Published: (2012-06-01)

Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer
by: Jiayu Chen, et al.
Published: (2021-10-01)